The mechanism and physiological functions
of heme oxygenase-2 (HO-2)-mediated
carbon monoxide (CO) production, accompanied by heme metabolism, have
been studied intensively in recent years. The enzymatic activity of
constitutively expressed HO-2 must be strictly controlled in terms
of the toxicity and chemical stability of CO. In this study, the molecular
interaction between HO-2 and caveolin-1 and its effect on HO action
were evaluated. An enzyme kinetics assay with residues 82–101
of caveolin-1, also called the caveolin scaffold domain, inhibited
HO-2 activity in a competitive manner. Analytical ultracentrifugation
and a hemin titration assay suggested that the inhibitory effect was
generated by direct binding of caveolin-1 to aromatic residues, which
were defined as components of the caveolin-binding motif in the HO-2
heme pocket. Herein, we developed a HO-2-based fluorescence bioprobe,
namely EGFP-Δ19/D159H, which was capable of quantifying heme
binding by HO-2 as the initial step in the CO production. The fluorescence
of EGFP-Δ19/D159H decreased in accordance with 5-aminolevulinic
acid-facilitated heme biosynthesis in COS-7 cells. In contrast, expression
of the N-terminal cytosolic domain of caveolin-1 (residues 1–101)
increased the probe fluorescence, suggesting that the cytosolic domain
of caveolin-1 potently inhibits the binding of heme to the heme pocket
of EGFP-Δ19/D159H. Taken together, our results suggest that
caveolin-1 is a negative regulator of HO-2 enzymatic action. Moreover,
our bioprobe EGFP-Δ19/D159H represents a powerful tool for use
in future studies addressing HO-2-mediated CO production.